Tag: GLP-1
-
Unusual PET-CT Scan Patterns Linked to GLP-1 Weight-Loss Drugs
Overview: A new imaging wrinkle around popular GLP-1 medications GLP-1 receptor agonists, a class of drugs that has surged in popularity for weight loss and type 2 diabetes management, are facing fresh scrutiny. While these medications—sold under names like Ozempic, Wegovy, and Mounjaro—continue to help many shed pounds, doctors are now noting unfamiliar patterns on…
-
Unusual GLP-1 Drug Side Effect Could Skew PET-CT Scans, Study Warns
GLP-1 drugs are reshaping weight loss—and now imaging, too GLP-1 receptor agonists, best known by brand names like Ozempic, Wegovy, and Mounjaro, have surged in popularity for their powerful weight‑loss effects. But as their use has exploded—driven by a 700% rise in the United States from 2019 to 2023—so too have reports of unusual side…
-
GLP-1 Drugs May Skew PET-CT Scans: A Hidden Risk for Cancer Detection
Understanding the emerging imaging challenge with GLP-1 medications GLP-1 receptor agonists, including popular drugs like Ozempic, Wegovy, and Mounjaro, have transformed weight loss and diabetes management. Yet as usage surged—reported to have risen about 700% in the United States from 2019 to 2023—so have reports of unusual side effects. A less obvious consequence is their…
-
Weight-Loss Injections and the Price of Rapid Change: A Real-Life Cautionary Tale
Understanding the Promise and the Peril of GLP-1 Weight-Loss Drugs Glucagon-like peptide-1 (GLP-1) medications, including tirzepatide sold as Mounjaro, have surged in popularity for rapid weight loss. By helping control appetite and slowing stomach emptying, these drugs offer a shortcut some people find irresistible. Yet medical experts emphasize that no treatment is risk-free, and side…
-
Rapid Weight-Loss Injections Led to Gallbladder Surgery: The Julie Riley Story
The lure of rapid weight loss Julie Riley, a 57-year-old pastry chef from Birmingham, spent her days between ovens, fondant, and the next big dessert idea. Standing 1.54 meters tall, she weighed about 76 kilograms at the start of her journey, a BMI around 32 that put her in the obesity range. To quiet the…
-
GLP-1 Weight-Loss Injections: 25kg Drop, Gallbladder Risks
The Promise of Rapid Weight Loss and the Reality GLP-1 receptor agonists used for obesity treatment have become a beacon for people seeking fast results. These medications mimic gut hormones that control appetite, slow digestion, and help reduce calorie intake. For many, the outcomes are dramatic enough to change daily habits. But the same therapy…
-
Wegovy and Ozempic: Could Semaglutide Help Alcohol Dependence?
The new front in addiction research: GLP-1 drugs and alcohol Semaglutide, the active ingredient in Wegovy (weight loss) and Ozempic (diabetes), is being explored beyond its approved uses. Anecdotal reports have noted that some people on these injections drink less alcohol, prompting researchers to study whether semaglutide could help those struggling with alcohol dependence. A…
-
Wegovy and Ozempic Could Help Alcohol Dependence: Early Findings
Background Wegovy and Ozempic are brand names for semaglutide, a GLP‑1 receptor agonist. While they are primarily used for obesity management and type 2 diabetes, researchers are beginning to explore whether these drugs might influence alcohol use disorders as well. In a small US study, investigators observed that some participants reduced their alcohol consumption while…
-
Semaglutide Could Aid Alcohol Dependence: Wegovy & Ozempic
New clues on semaglutide and alcohol dependence In recent years, semaglutide, the active ingredient in Wegovy and Ozempic, has drawn attention beyond weight loss and diabetes management. A small American study provides the first clinical hints that this GLP-1 receptor agonist could help people with alcohol use disorder by reducing the amount they drink during…
-
WHO Adds GLP-1s to Essential Medicines List
Introduction to WHO’s Essential Medicines List The World Health Organization (WHO) plays a crucial role in ensuring that essential medications are accessible to communities in need. The Model List of Essential Medicines (EML) is a guide for countries to prioritize medicines that are critical for public health, and the recent update announced on September 9,…